As­traZeneca plans to spend $535M-plus to ex­pand its R&D net­work and man­u­fac­tur­ing ops in France

UK-based As­traZeneca is steer­ing a sig­nif­i­cant amount of R&D and man­u­fac­tur­ing spend­ing to France,

On the Mon­day hol­i­day, the phar­ma gi­ant made a splash with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER